www.klinickafarmakologie.cz / KlinFarmakol Farm2021; 35(4): 126–129 / KLINICKÁ FARMAKOLOGIE A FARMACIE 129 PŘEHLEDOVÉ ČLÁNKY The Importance of Penetration Enhancers choice in Topical Products REFERENCES 1. Barton AFM. CRC Handbook of Solubility Parameters and Other Cohesion Parameters, Second Edition. 2017; 1–739. 2. Boelsma E, Tanojo HE, Boddé HE, Ponec M. Assessment of the Potential Irritancy of Oleic Acid on Human Skin: Evaluation In Vitro and In Vivo. Toxicol Vitr, 1996; 10: 729–742. 3. Boncheva M, Damien F, Normand V. Molecular organization of the lipid matrix in intact Stratum corneum using ATR-FTIR spectroscopy. Biochim Biophys Acta, 2008; 1778, 5: 1344–1355. 4. Cordero J, Camacho M, Obach R et al. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Eur J Pharm Biopharm, 2001; 51: 135–142. 5. Derry S, Moore RA, Gaskell H, McIntyre M, Wiffen PJ. Topical NSAIDs for acute musculoskeletal pain in adults. Cochrane Database Syst Rev, 2015; CD007402. 6. Hagen M, Baker M. Skin penetration and tissue permeation after topical administration of diclofenac. Curr Med Res Opin, 2017; 33: 1623–1634. 7. Ibrahim SA, Li SK. Effects of chemical enhancers on human epidermal membrane: Structure-enhancement relationship based on maximum enhancement (E(max)). J Pharm Sci, 2009; 98: 926–944. 8. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/ transdermal delivery. Ther Deliv, 2010; 1: 109–131. 9. Pradal J et all . Impor tance of the formulation in the skin delivery of topical diclofenac: not all topical diclofenac formulations are the same. J Pain Res. 2019; 12: 1149– 1154. 10. Pradal J et all. Comparison of Skin Permeation and Putative Anti-Inflammatory Activity of Commercially Available Topical Products Containing Ibuprofen and Diclofenac. J Pain Res. 2020; Nov 4, 13: 2805–2814. 11. Public Assessment Report DE/H/5493+6245+6603/001002/DC for Diclofenac AbZ Schmerzgel Diclox / Diclox forte Diclofenac-ratiopharm, 2020. Available online at: https://mri. cts-mrp.eu/Human/Downloads/DE_H_5493_002_PAR.pdf. Last accessed: 27 May 2021. 12. Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci, 2008; 11: 81s–110s. 13. Tanojo H, Junginger HE, Bodde HE. In vivo human skin permeability enhancement by oleic acid: Transepidermal water loss and Fourier-transform infrared spectroscopy. J Control Release, 1997; 47: 31–39. 14. Wiffen PJ, Xia J. Systematic review of topical diclofenac for the treatment of acute and chronic musculoskeletal pain. Curr Med Res Opin, 2020; 36: 637–650. 15. Williams AC, Barry BW. Penetration enhancers. Advanced Drug Delivery Reviews, 2012; 64: 128–137. 16. Zhang Q, Saad P, Mao G, Walters RM, Mack Correa MC, Mendelsohn R, Flach CR. Infrared spectroscopic imaging tracks lateral distribution in human stratum corneum. Pharm Res, 2014; 31: 2762–2773.
RkJQdWJsaXNoZXIy NDA4Mjc=